Recall Alert: Soaps and Sanitizers Pulled Over Bacteria Risk

A sweeping nationwide recall of soaps, sanitizers, and other skincare products has been announced after tests revealed the potential presence of bacteria that can cause dangerous infections, including sepsis.

The Food and Drug Administration (FDA) issued the notice on August 28, confirming that DermaRite Industries has recalled multiple hospital-grade and consumer products sold across the United States and Puerto Rico. The affected items were distributed widely, available not only through healthcare facilities but also online retailers like Amazon and big-box stores such as Sam’s Club.

Which Products Are Included?

The recall began in early August with a smaller group of soaps but has since been expanded to cover a full list of products. According to the FDA, all lots with expiration dates on or before August 2027 are affected.

The recalled products include:

• 4-N-1 no-rinse wash cream

• DermaCerin skin protectant moisturizing cream

• DermaFungal antifungal cream

• DermaKleen antiseptic lotion soap with vitamin E

• DermaMed skin protectant

• DermaSarra external analgesic

• Gel Rite instant gel hand sanitizer with vitamin E

• Hand E Foam foaming hand sanitizer with vitamin E

• KleenFoam antimicrobial foam soap with Aloe vera

• Lantiseptic skin protectant

• PeriGiene antiseptic cleanser

• PeriGuard skin protectant

• Renew Dimethicone skin protectant

• Renew Periprotect skin protectant

• Renew Skin Repair cream

• UltraSure antiperspirant and deodorant

Why the Recall Matters

The FDA reported that the products may be contaminated with Burkholderia cepacia complex (Bcc), a group of bacteria known to cause infections when it enters the body through cuts, wounds, or medical procedures.

For healthy adults, Bcc exposure may lead to relatively minor skin infections. But for people with weakened immune systems—including those undergoing cancer treatment, organ transplant recipients, or individuals with chronic illnesses—the risk is far more serious. If Bcc bacteria enter the bloodstream, it can trigger sepsis, the body’s extreme and life-threatening reaction to infection.

Sepsis is a major public health concern, affecting an estimated 1.7 million Americans each year. According to the Centers for Disease Control and Prevention (CDC), it can lead to tissue damage, organ failure, and death if not treated quickly.

Symptoms to Watch For

The FDA urged consumers and healthcare providers to monitor for signs of sepsis in anyone who may have used the recalled products. Symptoms can include:

• Clammy or sweaty skin

• Confusion or disorientation

• Extreme pain or discomfort

• Fever, chills, or feeling very cold

• High heart rate or weak pulse

• Shortness of breath

Immediate medical care is critical if any of these symptoms appear.

What Consumers Should Do

Health officials recommend that consumers check their bathroom cabinets, first aid kits, and healthcare supplies for any of the recalled DermaRite products. Any affected items should be discarded immediately.

Those who have experienced skin irritation, infection, or other symptoms after using the products should contact their healthcare provider. Patients who recently received care at a hospital or clinic may also want to confirm whether their facility used any of the recalled items.

DermaRite Industries has set up customer support for anyone with questions. Consumers can call 888-943-5190 or email dermarite5186@sedgwick.com for further guidance.

A Widespread Impact

Because DermaRite products are common in both consumer and healthcare settings, this recall is being treated as a significant public health issue. The FDA continues to monitor the situation and urges both healthcare providers and individuals to take immediate action if they have purchased or used the affected items.